Journal for ImmunoTherapy of Cancer
ISSN: 2051-1426
Publisher: BioMed Central
Publications (51)
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy (2024)
Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, et al.
Journal article
Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases (2024)
Oltmanns F, Vieira Antao AI, Irrgang P, Viherlehto V, Jörg L, Schmidt A, Wagner J, et al.
Journal article
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy (2024)
Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, et al.
Journal article
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG (2023)
Haist M, Stege H, Rogall F, Tan Y, von Wasielewski I, Klespe KC, Meier F, et al.
Journal article
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma (2023)
Maerkl F, Benmebarek MR, Keyl J, Cadilha BL, Geiger M, Karches C, Obeck H, et al.
Journal article
Accumulation of T-cell-suppressive PD-L1 high extracellular vesicles is associated with GvHD and might impact GvL efficacy (2023)
Baur R, Karl F, Böttcher-Loschinski R, Stoll A, Völkl S, Gießl A, Flamann C, et al.
Journal article
IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY (2022)
Zhou JG, Gaipl U, Ma H, Wang H
Conference contribution
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors (2022)
Borchmann S, Selenz C, Lohmann M, Ludwig H, Gassa A, Braegelmann J, Lohneis P, et al.
Journal article
Automated, scaled, transposon-based production of CAR T cells (2022)
Lock D, Monjezi R, Brandes C, Bates S, Lennartz S, Teppert K, Gehrke L, et al.
Journal article
BISPECIFIC ANTIBODIES ENABLE SYNTHETIC AGONISTIC RECEPTOR T CELL THERAPY IN MELANOMA (2022)
Benmebarek M, Maerkl F, Keyl J, Cadilha B, Geiger M, Karches C, Obeck H, et al.
Conference contribution